InvestorsHub Logo
Followers 8
Posts 99
Boards Moderated 0
Alias Born 12/02/2023

Re: None

Monday, 04/29/2024 11:11:23 AM

Monday, April 29, 2024 11:11:23 AM

Post# of 459172
Seems like the issues for annovis is the analysis they did wasn't pre-specified, the fact it's only based on 12 weeks and the ADL fail (though less of a problem with new FDA guidance) plus quite low cash. Also noticed they had about 50% screened out from being in the trial (though I suppose no worse than the BP trials).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News